Johnson & Johnson COVID-19 vaccine candidate demonstrates protection in pre-clinical studies

Tuesday, Aug 04, 2020

Johnson & Johnson on July 30 announced that its lead vaccine candidate protected against infection by SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies.